Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou X, Qiao G, Wang X, Song Q, et al. CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. Cancer Chemother Pharmacol 2017 Dec 14. pii: 10.1007/s00280-017-3500.
PMID: 29242966

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016